Cite

HARVARD Citation

    Vidal, S. et al. (2018). Efficacy and Safety of a Rapid Intravenous Injection of Ketamine 0.5 mg/kg in Treatment-Resistant Major Depression. Journal of clinical psychopharmacology. 38 (6), p. . [Online]. 
  
Back to record